maps glp 1 Mapped: GLP-1s across the U.S The expanding landscape of GLP-1
Description
Rita Kapoor

Eli Lilly confirmed this in their Phase 1 pharmacokinetic study: no clinically relevant differences in total tirzepatide exposure between the abdomen, thigh, and upper arm

Diabetes Obes Metab 2015;17:179-87
10.1016/j.brainres.2005.08.053 96 TakedaN.HasegawaS.MoritaM.MatsunagaT

Compounded formulations undergo sterility and potency testing equivalent to pharmaceutical manufacturing

And so, the system is already there to make these peptides functional. This delivery platform also allows the natural versions of these peptides to be used, potentially lowering the risk of side effects, he notes